Related Experiment Videos

Surfactant lavage and replacement in meconium aspiration syndrome with pulmonary hemorrhage

M Kaneko1, J Watanabe, E Ueno

  • 1Department of Pediatrics, Shizuoka Red Cross Hospital, Shizuoka-shi, Japan. src1@tokai.or.jp

Insights

Surfactant lavage and replacement effectively treated meconium aspiration syndrome (MAS) with pulmonary hemorrhage in two cases. This adjunctive therapy shows promise for improving outcomes in neonates with severe MAS.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Critical Care

Background:

  • Meconium aspiration syndrome (MAS) can lead to severe respiratory distress and pulmonary hemorrhage in newborns.
  • Pulmonary hemorrhage complicates MAS, increasing morbidity and mortality.
  • Current treatment strategies for MAS with pulmonary hemorrhage are limited.

Observation:

  • Two neonates with MAS complicated by pulmonary hemorrhage were treated with surfactant lavage and replacement.
  • The procedure involved lavage to clear meconium and hemorrhage, followed by surfactant instillation.
  • Minimal replacement doses of surfactant were administered post-lavage.

Findings:

  • Surfactant lavage and replacement demonstrated effectiveness as an adjunctive therapy in both cases.
  • The treatment appeared safe, with no reported adverse events.
  • Reduced surfactant replacement doses suggest enhanced efficacy of the lavage procedure.

Implications:

  • Surfactant lavage and replacement may be a viable and safe therapeutic option for MAS with pulmonary hemorrhage.
  • Further investigation through randomized controlled trials is warranted to confirm these findings.
  • This approach could potentially improve respiratory support and outcomes for affected neonates.

Related Concept Videos